Network
The key research areas of the IMB have successfully achieved high international visibility and recognition. This has been made possible through the successful acquisition of research funding in the form of a Cluster of Excellence, Special Research Areas (SFBs), doctoral programs, DocFunds and international large-scale projects (e.g., EU projects, LeDucq projects) as well as through numerous individual stand-alone project grants. As a result, there is strong external research funding through competitive third-party funds at the IMB.
Currently, the IMB participates in large-scale research projects. Furthermore, the IMB is leading in the BioHealth Field of Excellence of the University of Graz as well as the Cluster of Excellence MetAGE.
Publications in journals of highest international renown as well as the bestowal of prestigious awards such as the Wittgenstein Prize, the Louis-Jeantet Prize for Medicine, the Seneca Medal for Aging Research, and membership in the US Academy of Microbiology and the US National Academy of Science by members of the institute are clear indicators of the scientific quality and success of the IMB. This excellence is also reflected in translational activities such as patents, corporate collaborations, startup ventures and scientific journals.
MetAGE is an interdisciplinary network of researchers with the common goal of understanding the metabolic control of aging and age-related diseases.
BioHealth is a consortium of researchers from molecular biosciences, chemistry and pharmaceutical sciences. Together we work on the molecular understanding of diseases and their interventions.
This CRC brings together the expertise of scientists from Graz and Vienna to identify the links between lipid and energy metabolism and the pathogenesis of metabolic diseases such as obesity, type 2 diabetes, non-alcoholic fatty liver/steatohepatitis and cancer.
A multidisciplinary research team is using animal models, patient samples and organoid cultures to investigate how macrophages maintain the integrity of adipose tissue, liver and intestine and how they contribute to organ dysfunction in diseases such as obesity, colitis, cancer, cachexia or liver disease.
As a research alliance of the University of Graz, the Graz University of Technology, and the Medical University of Graz, BioTechMed-Graz strengthens cutting-edge research, cooperation and networking at the research location Graz.
The Open Laboratory Graz is our hands-on laboratory for the field of molecular biology.